Free Trial

Flora Growth (FLGC) Competitors

Flora Growth logo
$18.56 +0.56 (+3.11%)
Closing price 04:00 PM Eastern
Extended Trading
$18.53 -0.03 (-0.16%)
As of 04:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FLGC vs. VNRX, ESLA, KPTI, LTRN, MRSN, TPST, NBRV, RVPH, PDSB, and CALC

Should you be buying Flora Growth stock or one of its competitors? The main competitors of Flora Growth include VolitionRx (VNRX), Estrella Immunopharma (ESLA), Karyopharm Therapeutics (KPTI), Lantern Pharma (LTRN), Mersana Therapeutics (MRSN), Tempest Therapeutics (TPST), Nabriva Therapeutics (NBRV), Reviva Pharmaceuticals (RVPH), PDS Biotechnology (PDSB), and CalciMedica (CALC). These companies are all part of the "pharmaceutical products" industry.

Flora Growth vs. Its Competitors

VolitionRx (NYSE:VNRX) and Flora Growth (NASDAQ:FLGC) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, analyst recommendations, risk, media sentiment, earnings and dividends.

8.1% of VolitionRx shares are held by institutional investors. Comparatively, 36.0% of Flora Growth shares are held by institutional investors. 10.4% of VolitionRx shares are held by company insiders. Comparatively, 12.6% of Flora Growth shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, VolitionRx had 3 more articles in the media than Flora Growth. MarketBeat recorded 5 mentions for VolitionRx and 2 mentions for Flora Growth. VolitionRx's average media sentiment score of 1.18 beat Flora Growth's score of 0.26 indicating that VolitionRx is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
VolitionRx
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Flora Growth
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Flora Growth has higher revenue and earnings than VolitionRx. VolitionRx is trading at a lower price-to-earnings ratio than Flora Growth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
VolitionRx$1.32M36.51-$35.32M-$0.25-1.79
Flora Growth$52.37M0.25-$15.91M-$34.38-0.54

VolitionRx currently has a consensus price target of $3.50, suggesting a potential upside of 681.77%. Flora Growth has a consensus price target of $93.00, suggesting a potential upside of 401.08%. Given VolitionRx's stronger consensus rating and higher possible upside, equities research analysts clearly believe VolitionRx is more favorable than Flora Growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
VolitionRx
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.00
Flora Growth
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

Flora Growth has a net margin of -24.86% compared to VolitionRx's net margin of -2,321.14%. VolitionRx's return on equity of 0.00% beat Flora Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
VolitionRx-2,321.14% N/A -163.39%
Flora Growth -24.86%-261.57%-48.06%

VolitionRx has a beta of 1.27, suggesting that its stock price is 27% more volatile than the S&P 500. Comparatively, Flora Growth has a beta of 1.93, suggesting that its stock price is 93% more volatile than the S&P 500.

Summary

VolitionRx and Flora Growth tied by winning 8 of the 16 factors compared between the two stocks.

Get Flora Growth News Delivered to You Automatically

Sign up to receive the latest news and ratings for FLGC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FLGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FLGC vs. The Competition

MetricFlora GrowthMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$13.22M$10.84B$6.17B$10.68B
Dividend YieldN/A1.88%5.70%4.84%
P/E Ratio-0.5420.9229.4727.36
Price / Sales0.2528.14589.24132.03
Price / CashN/A25.1225.8230.35
Price / Book1.523.4912.526.69
Net Income-$15.91M$208.83M$3.32B$276.59M
7 Day Performance2.48%0.78%2.43%0.97%
1 Month Performance-31.76%1.19%8.78%3.95%
1 Year Performance-70.44%-8.19%62.11%36.40%

Flora Growth Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FLGC
Flora Growth
2.2259 of 5 stars
$18.56
+3.1%
$93.00
+401.1%
-71.3%$13.22M$52.37M-0.54280Short Interest ↑
Gap Up
VNRX
VolitionRx
2.9106 of 5 stars
$0.45
-2.5%
$3.50
+673.1%
-39.4%$48.71M$1.32M-1.2680Positive News
Gap Up
High Trading Volume
ESLA
Estrella Immunopharma
2.9029 of 5 stars
$1.50
+16.3%
$16.00
+966.7%
+101.1%$47.81MN/A-5.77N/APositive News
Short Interest ↓
High Trading Volume
KPTI
Karyopharm Therapeutics
4.2811 of 5 stars
$5.62
+2.2%
$18.20
+223.8%
-54.6%$47.69M$145.24M-0.39380
LTRN
Lantern Pharma
1.6322 of 5 stars
$4.41
+1.6%
$25.00
+466.9%
+15.4%$46.87MN/A-2.4820Gap Up
MRSN
Mersana Therapeutics
4.1561 of 5 stars
$9.91
+7.3%
$56.60
+471.1%
-81.2%$46.11M$40.50M-0.68150High Trading Volume
TPST
Tempest Therapeutics
1.471 of 5 stars
$11.53
+12.3%
$30.00
+160.2%
-29.1%$45.60MN/A-0.7920Gap Up
NBRV
Nabriva Therapeutics
N/AN/AN/AN/A$45.46M$35.59M0.0070
RVPH
Reviva Pharmaceuticals
2.9282 of 5 stars
$0.63
-3.8%
$4.86
+676.5%
-59.5%$45.06MN/A-0.965Gap Up
PDSB
PDS Biotechnology
1.2505 of 5 stars
$0.96
+0.9%
$10.00
+946.2%
-71.5%$44.55MN/A-1.0420
CALC
CalciMedica
3.2341 of 5 stars
$3.26
+3.2%
$16.00
+390.8%
-21.3%$44.22MN/A-2.0430

Related Companies and Tools


This page (NASDAQ:FLGC) was last updated on 10/20/2025 by MarketBeat.com Staff
From Our Partners